1. Home
  2. MRVI vs QUAD Comparison

MRVI vs QUAD Comparison

Compare MRVI & QUAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • QUAD
  • Stock Information
  • Founded
  • MRVI 2014
  • QUAD 1971
  • Country
  • MRVI United States
  • QUAD United States
  • Employees
  • MRVI N/A
  • QUAD N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • QUAD Publishing
  • Sector
  • MRVI Health Care
  • QUAD Consumer Discretionary
  • Exchange
  • MRVI Nasdaq
  • QUAD Nasdaq
  • Market Cap
  • MRVI 371.8M
  • QUAD 304.4M
  • IPO Year
  • MRVI 2020
  • QUAD 2010
  • Fundamental
  • Price
  • MRVI $2.42
  • QUAD $6.66
  • Analyst Decision
  • MRVI Hold
  • QUAD Strong Buy
  • Analyst Count
  • MRVI 10
  • QUAD 2
  • Target Price
  • MRVI $5.84
  • QUAD $9.30
  • AVG Volume (30 Days)
  • MRVI 1.5M
  • QUAD 339.1K
  • Earning Date
  • MRVI 08-11-2025
  • QUAD 10-27-2025
  • Dividend Yield
  • MRVI N/A
  • QUAD 4.50%
  • EPS Growth
  • MRVI N/A
  • QUAD N/A
  • EPS
  • MRVI N/A
  • QUAD N/A
  • Revenue
  • MRVI $219,830,000.00
  • QUAD $2,584,500,000.00
  • Revenue This Year
  • MRVI N/A
  • QUAD N/A
  • Revenue Next Year
  • MRVI $7.23
  • QUAD N/A
  • P/E Ratio
  • MRVI N/A
  • QUAD N/A
  • Revenue Growth
  • MRVI N/A
  • QUAD N/A
  • 52 Week Low
  • MRVI $1.67
  • QUAD $4.13
  • 52 Week High
  • MRVI $9.60
  • QUAD $9.13
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 49.60
  • QUAD 60.90
  • Support Level
  • MRVI $2.28
  • QUAD $6.35
  • Resistance Level
  • MRVI $2.47
  • QUAD $6.62
  • Average True Range (ATR)
  • MRVI 0.14
  • QUAD 0.25
  • MACD
  • MRVI -0.01
  • QUAD 0.02
  • Stochastic Oscillator
  • MRVI 27.45
  • QUAD 74.21

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About QUAD Quad Graphics Inc

Quad/Graphics Inc provides print and marketing services to help customers market their products, services, and contents. The company operates in the commercial segment of the printing industry. It operates through three divisions. The United States print and related services segment consists of the company's American operations. Besides the complete set of print and marketing solutions, this segment also manufactures ink. The international segment includes the company's printing business in Europe and Latin America and others countries. The corporate segment is engaged in the general and administrative activities as well as associated costs. The company almost generates all its revenue from the American domestic market..

Share on Social Networks: